Oregon · 2025 Regular Session · Bill
HB 3799: Relating to medical treatments with investigational products.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 3799 is a bill introduced in the Oregon House on February 27, 2025. According to its official title, it concerns: Relating to medical treatments with investigational products. Primary sponsor: Ben Bowman (Democratic). It lists 1 additional sponsor. Most recent recorded action (June 28, 2025): In committee upon adjournment.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an investigational product not approved by the United States Food and Drug Administration. Provides protections, including a waiver of liability, for health care practitioners, health care facilities, professional organizations or associations and manufacturers or distributors of investigational products that comply with the Act.
Sponsors
Sponsors by party (alphabetical): Democratic 1 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Ben Bowman | Primary sponsor | Democratic | House | 25 |
| Ed Diehl | Co-sponsor | Republican | House | 17 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- In committee upon adjournment.
- Public Hearing held.
- Referred to Behavioral Health and Health Care.
- First reading. Referred to Speaker's desk.